A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy

Journal of Urology

Volumn 174, Issue 3, 2005, Pages 882-887

  Vargas, Carlos ^a   Ghilezan, Michel ^a   Hollander, Mitchell ^a   Gustafson, Gary ^a   Korman, Howard ^a   Gonzalez, Jose ^a   Martinez, Alvaro ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Adverse effects; Brachytherapy; Prostate; Prostatic neoplasms

Indexed keywords

IRIDIUM 192; PALLADIUM 103;

ADULT; AGED; BRACHYTHERAPY; CANCER STAGING; DYSURIA; ERECTILE DYSFUNCTION; FOLLOW UP; GLEASON SCORE; HEMATURIA; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; REVIEW; SURVIVAL RATE; TRANSRECTAL ULTRASONOGRAPHY; URETHRA STRICTURE; URINARY FREQUENCY; URINARY TRACT DISEASE; URINE INCONTINENCE; URINE RETENTION;

EID: 23744432859     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000169136.55891.21     Document Type: Article

References (21)

1. Kupelian, P. A., Potters, L., Khuntia, D., Ciezki, J. P., Reddy, C. A., Reuther, A. M. et al: Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/ external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys, 58: 25, 2004
2. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A. et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280: 969, 1998
3. Zelefsky, M. J., Hollister, T., Raben, A., Matthews, S. and Wallner, K. E.: Five-year biochemical outcome and toxicity with transperineal CT-planned permanent 1-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys, 47: 1261, 2000
4. Stock, R. G., Stone, N. N., Dahlal, M. and Lo, Y. C.: What is the optimal dose for 1251 prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms. Brachytherapy, 1: 83, 2002
5. Blasko, J. C., Grimm, P. D., Sylvester, J. E., Badiozamani, K. R., Hoak, D. and Cavanagh, W.: Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys, 46: 839, 2000
6. Martinez, A. A., Pataki, I., Edmundson, G., Sebastian, E., Brabbins, D. and Gustafson, G.: Phase II prospective study of the use of conformai high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int J Radiat Oncol Biol Phys, 49: 61, 2001
7. Yoshioka, Y., Nose, T., Yoshida, K., Inoue, T., Yamazaki, H., Tanaka, E. et al: High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys, 48: 675, 2000
8. Brenner, D. J., Martinez, A. A., Edmundson, G. K., Mitchell, C., Thames, H. D. and Armour, E. P.: Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/ beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys, 52: 6, 2002
9. Ghilezan, M., Vargas, C., Gustafson, G., Kestin, L., Chen, P., Brabbins, D. et al: Erectile dysfunction (ED) after prostate cancer brachytherapy as sole treatment modality. The William Beaumont Hospital's experience with HDR vs. LDR (Pd103 permanent implants). Presented at Joint Brachytherapy Meeting GEC/ESTRO-ABS-GLAC, Barcelona, Spain, 2004
10. Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W. et al: Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA, 283: 354, 2000
11. Stock, R. G. and Stone, N. N.: Importance of post-implant dp-simetry in permanent prostate brachytherapy. Eur Urol, 41: 434, 2002
12. Zelefsky, M. J., Yamada, Y., Marion, C., Sim, S., Cohen, G., Ben-Porat, L. et al: Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys, 55: 956, 2003
13. Beyer, D. C., Shapiro, R. H. and Puente, F.: Real-time optimized intraoperative dosimetry for prostate brachytherapy: a pilot study. Int J Radiat Oncol Biol Phys, 48: 1583, 2000
14. Stone, N. N., Roy, J., Hong, S., Lo, Y. C. and Stock, R. G.: Prostate gland motion and deformation caused by needle placement during brachytherapy. Brachytherapy, 1: 154, 2002
15. Martin, T., Baltas, D., Kurek, R., Roddiger, S., Kontova, M., Anagnostopoulos, G. et al: 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol, 180: 225, 2004
16. Lee, N., Wuu, C. S., Brody, R., Laguna, J. L., Katz, A. E., Bagiella, E. et al: Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys, 48: 1457, 2000
17. Krupski, T., Bissonette, E. A., Petroni, G. R. and Theodorescu, D.: The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapy. Eur Urol, 43: 467, 2003
18. Beaulieu, L., Archambault, L., Aubin, S., Oral, E., Taschereau, R. and Pouliot, J.: The robustness of dose distributions to displacement and migration of 1251 permanent seed implants over a wide range of seed number, activity, and designs. Int J Radiat Oncol Biol Phys, 58: 1298, 2004
19. Kucway, R., Vicini, F., Huang, R., Stromberg, J., Gonzalez, J. and Martinez, A.: Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol, 167: 2443, 2002
20. Terk, M. D., Stock, R. G. and Stone, N. N.: Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol, 160: 1379, 1998
21. Merrick, G. S., Butler, W. M., Wallner, K. E., Murray, B., Allen, Z., Lief, J. H. et al: The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy. Brachytherapy, 3: 22, 2004